JACOBS LEVY EQUITY MANAGEMENT, INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$2,219,072
+273.2%
2,264,359
+429.3%
0.01%
+333.3%
Q2 2023$594,631
+140.5%
427,792
+175.1%
0.00%
+50.0%
Q1 2023$247,250
-72.8%
155,503
+6.5%
0.00%
-66.7%
Q4 2022$909,699
-0.3%
146,019
+316.3%
0.01%
-25.0%
Q4 2020$912,000
-29.8%
35,072
+0.3%
0.01%
-38.5%
Q3 2020$1,299,000
-34.5%
34,952
-9.5%
0.01%
-38.1%
Q2 2020$1,982,000
+64.8%
38,620
+1.2%
0.02%
+40.0%
Q1 2020$1,203,000
-51.1%
38,159
-7.5%
0.02%
-37.5%
Q4 2019$2,460,000
+107.8%
41,247
+27.7%
0.02%
+60.0%
Q3 2019$1,184,000
-18.0%
32,310
+4.1%
0.02%
-25.0%
Q2 2019$1,444,000
+13.3%
31,050
-2.1%
0.02%
+11.1%
Q1 2019$1,274,000
+239.7%
31,720
+289.2%
0.02%
+157.1%
Q4 2018$375,000
+7.8%
8,150
+3.8%
0.01%
+40.0%
Q3 2018$348,000
+11.2%
7,850
-57.6%
0.01%
-28.6%
Q1 2016$313,00018,5000.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders